,28 Thirty years ago, a mouse monoclonal anti-IL-6 Ab was used to treat hematological cancers and renal cell carcinoma with significant activity on inflammatory symptoms and occasional antitumor activity, but limited duration of activity with the development of anti-mouse Ab.6 This evidence concerns the gene IL6 and hereditary clear cell renal cell carcinoma.